Cisec

Quick links to important sections

Cisec

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cisec

Property Description
Active ingredient Omeprazole (INN)
Form Delayed-release capsule, IV powder
Pharmacological class Proton Pump Inhibitor (PPI)
Common purpose Control of excess stomach acid
Origin Synthetic

What Type of Medicine is Cisec (Omeprazole)?

Cisec is a synthetic pharmaceutical preparation containing the active ingredient Omeprazole, a compound chemically defined as a substituted benzimidazole. This medicine is classified within the Proton Pump Inhibitor (PPI) pharmacological class, one of the primary categories of drugs used to control the output of gastric acid. Omeprazole itself is a synthetic compound supplied as a racemic mixture of two enantiomers and is often clinically recognized for its reliable efficacy in systemic acid control. The classification as a PPI is paramount, signifying that the medicine belongs to a class specifically engineered for profound acid suppression.

Cisec's Form and General Therapeutic Purpose

The medication is commonly administered via the oral route in the form of a delayed-release capsule, although a form for intravenous (IV) injection is also used in clinical settings. The capsule utilizes enteric-coated pellets, a distinctive feature necessary because Omeprazole is an acid-labile compound that must be protected from destruction by stomach acid before it can be absorbed. The core general therapeutic purpose of Cisec is to establish a powerful and prolonged antisecretory effect.

This effect is accomplished by the active component forming an irreversible blockade of the H^+K^+-ATPase (the proton pump), the enzyme responsible for pushing hydrogen ions into the stomach. This mechanism successfully suppresses acid production, providing the benefit of reducing excess stomach acid and managing gastric acid hypersecretion, a critical step in healing and symptom management.

What side effects are possible with Cisec?

Possible Side Effects and Safety Information

The following details the official adverse reactions and high-level safety characteristics of omeprazole (Cisec), as documented in governmental regulatory sources.

Adverse Reactions by Frequency and System

Side effects are classified by frequency according to regulatory standards, with the most frequently documented reactions affecting the Gastrointestinal and Nervous Systems.

Classification System-Organ Class Examples
Common (May affect up to 1 in 10 people) Gastrointestinal (abdominal pain, diarrhea, flatulence, nausea, vomiting), Nervous System (headache).
Uncommon Nervous System (dizziness, somnolence, paresthesia), Skin (rash, pruritus), Psychiatric (insomnia).
Rare Blood and Lymphatic System (leukopenia, thrombocytopenia), Immune System (angioedema), Skin (severe cutaneous reactions).

Serious Reactions and Contextual Safety Patterns

The official labeling documents rare but clinically significant adverse reactions, including severe skin reactions such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which are classified as serious. The medication is also noted as increasing the risk for C. difficile-associated diarrhea.

Long-term use (typically one year or more) is associated with specific safety considerations. These include an increased risk of bone fractures of the hip, wrist, or spine, and the potential development of hypomagnesemia (low magnesium levels). The label also documents that symptomatic response to omeprazole does not exclude an underlying gastric malignancy.

Safety notes for specific groups address an increased susceptibility to these duration-related risks in older adults and caution regarding individuals with severe hepatic impairment due to altered drug clearance.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Cisec (Omeprazole) overdose details specific, documented manifestations and mandated emergency actions.

Documented Overdose Presentations

Classification Manifestations Reported in Regulatory Documents
Central Nervous System Confusion, drowsiness, headache.
Cardiovascular/General Tachycardia (fast heart rate), flushing, diaphoresis (increased sweating).
Other Symptoms Blurred vision, nausea, vomiting, dry mouth.

Overdoses have been reported following exposures of up to 900 mg. However, regulatory documents classify the reported symptoms as typically transient, and no serious clinical outcome has been reported in these rare cases.


Required Emergency Actions

No specific antidote is known for Omeprazole overdosage, and the medicine is not readily dialyzable. Treatment must therefore be symptomatic and general supportive measures. The regulatory labeling mandates that in the event of a suspected overdose, individuals must get medical help or contact a Poison Control Center right away for assessment and supportive care. This action is required even though serious outcomes are not commonly documented.

Therapeutic Uses of Cisec

Cisec is generally used to manage symptoms associated with acute or episodic changes and conditions that involve inflammatory or irritative processes caused by high levels of stomach acid. The medication supports a high level of acid management, which helps with therapeutic support across several domains. The medication is used to address symptoms of GERD, ulcers, and pathological hypersecretory conditions.


Key Therapeutic Applications

Cisec is considered relevant in therapeutic domains involving heightened physiological activity (acid production). It is applied in addressing conditions like Gastroesophageal Reflux Disease (GERD) and its most common manifestations, including persistent heartburn and uncomfortable acid regurgitation. It is applied in addressing Gastric and Duodenal Ulcers, and may be part of symptomatic management applied during the eradication of H. pylori, or may assist with ulcer prophylaxis for individuals on long-term NSAID therapy.

“The control of excess stomach acid provides supportive relief when symptoms interfere with routine activities.”

Patient Benefit and Symptom Support

Cisec is commonly used to help with relief from the pain and burning associated with these conditions. It may assist in the therapeutic support of erosive esophagitis and is applied in clinical settings that involve acute or unstable symptom patterns, such as Zollinger-Ellison Syndrome. The medication contributes to easing the overall symptom load and supports general well-being during symptomatic phases by easing symptoms during episodes of heightened discomfort.

Quick Fact: Relief for Heartburn

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Regulatory Eligibility Profile

Contraindicated Populations

Regulatory documents stipulate that Cisec (Omeprazole) must not be used by patients with a known hypersensitivity to the active ingredient, any component of the formulation, or to other substituted benzimidazoles (the drug class). Use is also absolutely prohibited for patients who are taking specific antiviral medicines, such as rilpivirine or nelfinavir.

Age-Related Eligibility

Age Group Eligibility Status (Regulatory)
Adults Approved for all labeled indications.
Children 1 Year Approved for symptomatic GERD and maintenance of healing of Erosive Esophagitis.
Infants < 1 Month Safety and efficacy not established for treatment of Erosive Esophagitis.

Conditional Use and Restrictions

Eligibility is restricted for certain populations and conditions as noted in official labels:

  • Hepatic Impairment: Patients with liver disease must use the medicine with caution, and a reduced daily dose is often recommended by regulators due to reduced drug clearance.
  • Renal Impairment: No dose adjustment is typically required for patients with kidney function impairment.
  • Gastric Malignancy: Regulatory warnings state that the presence of gastric malignancy must be excluded before initiating treatment in adults, as symptom relief may mask the condition.

Pregnancy and Lactation

  • Pregnancy: Use is generally not contraindicated based on available human data.
  • Lactation: Omeprazole is excreted into human milk; regulatory documents advise a decision be made to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Cisec (omeprazole) can interact with a wide range of prescription and over-the-counter medicines, herbal products, vitamins, and supplements. These interactions can affect how well Cisec works, or alter the levels and effects of other products in your body, potentially leading to increased side effects or reduced effectiveness.

Reduced Effectiveness of Other Drugs

Cisec, a proton pump inhibitor, decreases stomach acid, which can significantly reduce the absorption and effectiveness of certain medicines that require a more acidic environment. Examples include some HIV medications (such as atazanavir and rilpivirine) and certain antifungals (like ketoconazole and posaconazole).

Increased Levels of Other Drugs

Cisec can inhibit certain liver enzymes (CYP2C19), leading to higher concentrations of some medications in the bloodstream. This may increase the risk of side effects or toxicity from drugs like diazepam (for anxiety/seizures), phenytoin (for seizures), digoxin (for heart failure), and warfarin (a blood thinner). Close monitoring is often required with these combinations.

Specific Noteworthy Interactions

  • Clopidogrel: Cisec can decrease the effectiveness of the antiplatelet medication clopidogrel, which may increase the risk of serious cardiovascular events. This combination is generally discouraged.
  • Methotrexate: Concurrent use can elevate the concentration of methotrexate (used for cancer and autoimmune conditions) in the blood, increasing the risk of toxicity.
  • St. John’s Wort: This herbal supplement may decrease the concentration of Cisec, potentially reducing its therapeutic effect.

Always inform your healthcare provider of all products you are taking before starting Cisec, as dose adjustments or alternative treatments may be necessary.

Mechanism of Action

How Cisec Works


Targeted Modulation of Specific Receptor Systems

Cisec exerts its effect by directly engaging with specific receptor systems on cell surfaces, functioning as either an agonist or antagonist to alter the cell's response to natural signaling molecules. This precise interaction initiates the drug's mechanism, resulting in the modulation or suppression of activity within specific signaling processes localized to key regulatory pathways.


Influence on Downstream Signaling Cascades

The binding event at the receptor level leads to a controlled modification of intracellular signaling cascades. Cisec's action alters the sequence of molecular events inside the cell, which limits the propagation and amplification of heightened pathway activation and results in the consequent suppression of specific mediator release. This modification affects signal transduction, influencing enzyme and messenger activity within the cytoplasm.


Modulating Core Biological Feedback Systems

By controlling the signal flow within these molecular cascades, Cisec influences the activity of core biological feedback systems. This mechanism results in the modulation of physiological response patterns and shapes the resulting systemic activity by leading to specific alterations in physiological activity in the targeted systems.

Dosage and Administration Information

How to Use Cisec (Omeprazole)

Cisec is administered primarily via the oral route as a delayed-release capsule, tablet, or suspension. An intravenous (IV) formulation is available for clinical use when oral intake is not possible. The dosing schedule is highly dependent on the specific condition, but the standard pattern for most conditions is once daily, typically taken before eating to optimize its action.

Official Dosing and Frequency Patterns

Adult dosing ranges from 10 mg to 40 mg once daily for managing common conditions, such as the healing and maintenance of ulcers and erosive esophagitis. For pathological hypersecretory conditions, initial daily doses may be 60 mg, with higher totals requiring administration in divided doses throughout the day when the total exceeds 80 mg.

Treatment follows distinct time patterns: initial healing courses are typically short-term (e.g., four to eight weeks), whereas maintenance therapy for certain conditions can extend to long-term use.

Administration Requirements

Delayed-release capsules and tablets must be swallowed whole with fluid and must not be crushed or chewed. This instruction is necessary to preserve the enteric coating that protects the active substance from stomach acid. If a dose is missed, it should be taken as soon as possible, but the missed dose should be skipped if it is almost time for the next scheduled dose, and a double dose must be avoided. Dose reduction may be required for patients with hepatic impairment. Conversely, no dose adjustment is typically needed for older adults or individuals with renal impairment.

Recent Clinical Evidence

Research evidence / Overview of studies for Cisec (Omeprazole)


Evidence for Managing Gastroesophageal Reflux Disease (GERD) and Heartburn

Cisec was studied for conditions characterized by fluctuating or episodic manifestations, such as common, persistent heartburn and GERD. The evidence landscape includes numerous short-term randomized controlled trials (RCTs) and systematic reviews applied in research contexts involving fluctuating or unstable symptoms. The findings describe patterns observed in the studies where a greater proportion of participants reported fewer symptoms of discomfort during the study period compared to observed patterns in groups receiving an inactive treatment (placebo).

Evidence for the youngest pediatric patients (infants) is limited, and findings were heterogeneous in some small observational settings. Research does not determine whether an individual will respond similarly, and the evidence quality varies across studies regarding long-term, continuous management of symptomatic GERD.


Evidence for Healing Erosive Esophagitis and Preventing Recurrence

Cisec was evaluated in studies for erosive esophagitis, a condition where symptoms are linked to inflammatory states that cause damage to the esophagus. The evidence base includes many controlled clinical trials where objective measures, such as endoscopic healing rates (confirming tissue repair using medical imaging), were the primary outcomes monitored. Findings from maintenance trials describe patterns related to a lower reported incidence of recurrence compared to groups switched to placebo after initial healing.

While data show patterns related to high short-term healing rates, the long-term effects are not fully established. Follow-up durations were limited, as controlled maintenance studies typically do not extend past one year. There is limited information for long-term outcomes beyond this period.


Evidence for Treating Peptic Ulcer Diseases

The evidence for active gastric and duodenal ulcers includes short-term Randomized Controlled Trials (RCTs) and subsequent meta-analyses where researchers examined ulcer healing rates. Studies report how ulcers evolved in the observed populations within defined time intervals (e.g., 4 to 8 weeks). Cisec was also evaluated in studies for ulcer prophylaxis (prevention) to examine the reported incidence of new ulcer formation in patients taking long-term Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

One limitation is that evidence related to using Cisec in regimens for the eradication of the H. pylori bacteria is found within studies using multi-drug combinations, meaning the specific contribution of Cisec was not isolated in those trials.

Key Studies & References

  1. Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants
  2. Omeprazole 2021 (Guidelines summary for GERD and Esophagitis)
  3. Omeprazole - StatPearls (NIH Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Cisec (FAQ)


Q: Is Cisec a medicine that requires a prescription?

Omeprazole is available in both prescription strengths, which are used for certain diseases like ulcers or severe GERD, and over-the-counter (OTC) strengths. The OTC versions are typically a lower dose and are approved for the descriptive treatment of frequent heartburn.


Q: What is the difference between Cisec and similar over-the-counter heartburn remedies?

According to official product information, Cisec is classified as a Proton Pump Inhibitor (PPI). This class works by blocking the final step of acid production in the stomach. Other heartburn remedies, such as H2 blockers and antacids, reduce acid or neutralize it using different physiological processes.


Q: Is Cisec the same type of drug as Prilosec or Nexium?

Yes, Cisec is the same active ingredient, omeprazole, as is found in the medicine branded as Prilosec. Both Cisec and Nexium (esomeprazole) are classified in the same class of medicines, the Proton Pump Inhibitors (PPIs).


Q: Is there a generic version of Cisec available?

Yes, the active ingredient in Cisec is Omeprazole, which is the official generic name for the medicine. Both prescription and over-the-counter (OTC) generic versions of omeprazole are available.


Q: Does Cisec have an immediate effect, or does it build up over time?

Official product information indicates that Cisec begins to exert its effect within one hour of the dose. However, the full therapeutic effect, where the maximum level of acid suppression is reached, usually requires taking the medicine regularly for one to four days.


Q: What is the difference between Cisec capsules and tablets?

Cisec is available as both delayed-release capsules and delayed-release tablets. Both forms are designed to protect the active ingredient from stomach acid until it reaches the intestine. Official administration requirements state that both the capsules and tablets must be swallowed whole with fluid.


Q: Does Cisec need to be taken at a specific time of day?

The official prescribing instructions describe Cisec as typically being taken once daily. The medicine should be taken before eating to help optimize its action.


Q: If I stop taking Cisec, will my original symptoms come back quickly?

Official information based on pharmacokinetic studies indicates that when Cisec is stopped, acid secretion returns gradually over approximately three to five days. Some reports describe a phenomenon of 'rebound acid hypersecretion,' where symptoms may temporarily be heightened upon abrupt discontinuation.


Q: Does taking Cisec affect blood pressure readings?

Official safety information notes that high blood pressure (hypertension) is not listed as a common side effect in clinical trials. However, postmarketing experience reports of high blood pressure have been associated with omeprazole use, and the safety profile continues to be monitored.


Q: Does Cisec interact with birth control pills?

According to regulatory documents, there is no established clinically significant interaction between Cisec and hormonal contraceptive pills. This means the effectiveness of birth control is generally not expected to be reduced by taking Cisec.


Q: Is there any known interaction between Cisec and alcohol consumption?

Official regulatory documents do not list a specific interaction between omeprazole and alcohol consumption.


Q: Can I take pain relievers like Tylenol or Advil while on Cisec?

The official regulatory label does not specifically list an interaction between omeprazole and common over-the-counter pain relievers such as acetaminophen or ibuprofen. Information on combining medicines, particularly for individual use, is best reviewed by a healthcare provider.


Q: Is Cisec generally suitable for teenagers?

Regulatory documents indicate that omeprazole is approved for use in children aged one year and older for specific conditions, such as symptomatic GERD or the maintenance of healing of erosive esophagitis. The appropriate use and dosage for adolescents are determined based on the condition being treated.


Q: Why is Cisec sometimes recommended before surgery?

Official information notes that in seriously ill or hospitalized patients, omeprazole can be used for prophylaxis. This means it is sometimes administered to prevent upper gastrointestinal tract bleeding, which can be a concern in perioperative care.


Q: Does Cisec affect liver enzyme levels?

According to regulatory documents, Cisec can inhibit certain liver enzymes, such as CYP2C19, which affects how other medicines are processed by the body. For patients with severe liver impairment, a reduced daily dose is often recommended due to changes in how the drug is cleared.


Q: What does the research say about Cisec's long-term effectiveness?

Clinical studies show patterns that support the long-term effectiveness of Cisec, specifically for the maintenance of healing in conditions like erosive esophagitis. However, official information notes that the follow-up duration for controlled trials supporting long-term use is often limited.


Q: Does research show Cisec is effective for nocturnal heartburn?

Research reviewed by regulatory bodies describes evidence for the effectiveness of Cisec for the treatment of general symptoms of GERD, which includes heartburn that can occur during the night. Official information notes that the medicine’s mechanism of prolonged acid suppression addresses these symptoms.


Q: What is the safety classification of Cisec in regulatory databases?

In US regulatory databases, omeprazole is assigned to Pregnancy Category C. This classification indicates that animal studies have shown potential risk, but adequate and well-controlled studies in human pregnancies are not available.

How should Cisec be stored and disposed of?

Storage and Disposal Requirements for Cisec

Official regulatory documents require that Cisec (Omeprazole) be stored under specific conditions to maintain its stability, as the medicine is sensitive to environment factors.


Storage Conditions

Requirement Rule
Temperature Store below 30 C. Do not refrigerate or freeze.
Protection Keep in the original container, protected from moisture and light.
Child Safety Keep out of the sight and reach of children.

️ Disposal Instructions

Dispose of unused or expired Cisec according to local regulations, such as using a community drug take-back program. The medicine must not be thrown away into wastewater (flushed down the toilet or poured down a sink) to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cisec found in:

A-Z Index: